Miranda

CSL has announced plans to expand its US presence over the next five years (as reported on November 18, 2025) resulting in approximately $1.5 billion in US capital investments. These…

Merck & Co. has agreed to acquire Cidara Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company developing drug-Fc conjugate therapeutics, for $9.2 billion.  Cidara is using its proprietary Cloudbreak platform…

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Avantor, BioDuro, Gattefossé, Nanoform, and Pace Life Sciences. Biologics Manufacturing* Thermo Fisher Scientific Opens Advanced Therapies Collaboration CenterFormulation Development/Drug…

A roundup of news from Moderna, J&J/Halda, Alkermes/Avadel, Halozyme/Elektrofi, Lilly, and Teva Pharmaceutical. Highlights below. Manufacturing News*Moderna Onshoring Drug-Product Mfg for mRNA Medicines to USM&A News* J&J To Acquire Halda…

Bavarian Nordic, a Hellerup, Denmark-based vaccine company, has entered into an announcement agreement for an all-cash recommended purchase offer of approximately DKK 19 billion ($2.91 billion) with a private equity…

Merck & Co. has launched a new multiyear optimization to generate an expected $3.0 billion in annual cost savings from productivity actions, which the company says will be fully reinvested…

Novo Nordisk has appointed Maziar Mike Doustdar, currently Novo Nordisk’s Executive Vice President of International Operations, as President and Chief Executive Officer, effective August 7, 2025. He succeeds Lars Fruergaard Jørgensen,…

Bristol Myers Squibb (BMS) and Bain Capital have announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new therapies for autoimmune diseases. The newly formed company…

Evotec and Sandoz have signed a non-binding term sheet on the planned sale of Just–Evotec Biologics EU,  Evotec’s continuous biomanufacturing unit in Toulouse, France, to Sandoz for approximately $300 million.  …

Simtra BioPharma Solutions, a CDMO specializing in injectable medicines, reports that it has purchased a 65-acre property in Bloomington, Indiana, with more than 300,000 square feet of available space for…